Lombard Odier Asset Management (USA)’s Nautilus Biotechnolgy NAUT Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$96.8K	–	405
2023 Q2	$96.8K	Hold	25,000	–	–	﹤0.01%	334
2023 Q1	$69.3K	Sell	25,000 -25,000	-50%	-$52.4K	﹤0.01%	297
2022 Q4	$90K	Hold	50,000	–	–	﹤0.01%	314
2022 Q3	$106K	Hold	50,000	–	–	﹤0.01%	326
2022 Q2	$135K	Hold	50,000	–	–	0.01%	297
2022 Q1	$217K	Hold	50,000	–	–	0.01%	264
2021 Q4	$259K	Hold	50,000	–	–	0.01%	286
2021 Q3	$307K	Hold	50,000	–	–	0.01%	270
2021 Q2	$505K	Buy	+50,000	New	+$542K	0.02%	239

Other funds holding NAUT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

AEPLI

AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s NAUT Position: Q3 2023 in Review

Lombard Odier Asset Management (USA) sold out of Nautilus Biotechnolgy (NAUT) in Q3 2023, closing a stake of 25,000 shares — an estimated $96.8K sold.

Lombard Odier Asset Management (USA) first reported a position in NAUT in Q2 2021 and held it in 9 quarters. The position peaked at $505K in Q2 2021. 75 funds tracked by Wall St. Rank hold NAUT as of Q3 2023.

Lombard Odier Asset Management (USA) reported no remaining Nautilus Biotechnolgy position as of Q3 2023 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 25,000 Nautilus Biotechnolgy shares in Q3 2023, an estimated $96.8K.
Lombard Odier Asset Management (USA) first reported a position in Nautilus Biotechnolgy in Q2 2021 and held it in 9 quarters.
Lombard Odier Asset Management (USA)'s Nautilus Biotechnolgy position peaked at $505K in Q2 2021.
75 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2023.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2023, filed 14 Nov 2023.